Community Health Workers and mHealth for Sickle Cell Disease Care
Community Health Workers and Mobile Health for Emerging Adults Transitioning Sickle Cell Disease Care
1 other identifier
interventional
405
1 country
5
Brief Summary
This study will compare the effectiveness of two self-management support interventions-Community Health Workers (CHW) and mobile health (mHealth)-versus enhanced usual care to improve health-related quality of life and acute care use for transitioning youth with sickle cell disease (SCD), and identify and quantify mediators and moderators of intervention treatment effects.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2019
Longer than P75 for not_applicable
5 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 24, 2018
CompletedFirst Posted
Study publicly available on registry
August 27, 2018
CompletedStudy Start
First participant enrolled
January 15, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
August 31, 2024
CompletedDecember 4, 2024
December 1, 2024
5.6 years
August 24, 2018
December 2, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Health-Related Quality of Life (HRQOL)
Health-Related Quality of life will be assessed with the PedsQL Sickle Cell Disease (SCD) Module. The PedsQL Sickle Cell Disease Module is a well-validated for use in adolescents and young adults with chronic disease and use a Likert response scale, with higher scores indicating better HRQOL and lower SCD symptoms and problems. The PedsQL SCD Module is a 43-item that measures nine scales: Pain and Hurt (9 items), Pain Impact (10 items), Pain Management and Control (2 items), Worry I (5 items), Worry II (2 items), Emotions (2 items), Treatment (7 items), Communication I (3 items), and Communication II (3 items).
Baseline, 6 months, 12months, and 18 months.
Secondary Outcomes (7)
Sickle cell disease knowledge
Baseline, 6months, 12 months, 18 months
Transition Readiness
Baseline, 6 months, 12 months, 18 months
Social Support
Baseline, 6 months, 12 months, 18 months
Coping skills
Baseline, 6 months, 12 months, 18 months
Education and vocational planning
Baseline, 6 months, 12 months, 18 months
- +2 more secondary outcomes
Study Arms (3)
Enhanced Usual Care
NO INTERVENTIONEnhanced usual care will be standardized across sites with transition/transfer of care checklists that will be used at all sites. Enhanced usual care will minimally include (1) patient seen by the pediatric provider with the parent outside the examination room, (2) a social work consult to screen and address sociodemographic risk factors, (3) information on health insurance adequacy provided to patient, (4) adult hematologist identified, (5) adult primary care provider identified, (6) medical release signed, and (7) medical record viewable or sent to adult provider.
Peer Community Health Worker
EXPERIMENTALThe CHW program will primarily be modeled after the highly successful IMPaCT Program developed by the Penn Center for Community Health Workers and CHOP's Youth CHW Program for Pediatric to Adult Transitions developed by our research team, which were both developed with high levels of patient input. SCD specific content and expertise from the CHW Program through the Sickle Cell Disease Association of American Philadelphia Delaware Valley Chapter and other published models will be included. Components will include: 1) development of patient-centered goals and individualized action plan around self-care, symptom tracking, and transition to adult care; 2) provision of information, skills, and tips; and 3) tailored peer support using telephone calls and/or visits
Mobile Health
EXPERIMENTALAll participants enrolled in the mHealth arm will download an enhanced version of iManage, which was developed by Co-Investigator Lori Crosby at and adolescents and young adult patients with SCD. Components include: 1) development of patient-centered goals around self-care, symptom tracking, and transition to adult care; 2) provision of information, skills, and tips; 3) virtual peer support where users can encourage others to complete goals, forms teams, and interact with other youth with SCD; and 4) daily symptom tracking and visual tracking of goal completion. Investigators will add with daily tailored texting.
Interventions
Participants will be communicating with their CHWs on a weekly basis, which is consistent with other successful community health worker protocols with published efficacy. Community Health Workers will be peers with sickle cell disease, who have successfully transitioned and are under 30 years of age.
A mobile health application created as a resource for young adults transitioning.
Eligibility Criteria
You may qualify if:
- Males or females age 17 years or older
- Have sickle cell disease, defined as those individuals with HbSS, HbSC, HbSβ0Thal, HbSβ+Thal genotypes
- Receive care at a participating pediatric sickle cell disease center.
- Appropriate for transfer to an adult hematologist within 12 months
You may not qualify if:
- Individuals with an intellectual disability that is severe enough that the individual would not have the capacity to interact with a mobile or web-based program even with assistance or have a conversation with a community health worker (i.e. non-verbal). Individuals without access to a mobile device, tablet or computer.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Children's Hospital of Philadelphialead
- St. Christopher's Hospital for Childrencollaborator
- Children's Hospital Medical Center, Cincinnaticollaborator
- Steven and Alexandra Cohen Children's Medical Centercollaborator
- Connecticut Children's Medical Centercollaborator
- Patient-Centered Outcomes Research Institutecollaborator
Study Sites (5)
Connecticut Children's Medical Center
Hartford, Connecticut, 06106, United States
Cohen's Children's Medical Center
New Hyde Park, New York, 11040, United States
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, 45229, United States
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, 19104, United States
St. Christophers Hospital for Children
Philadelphia, Pennsylvania, 19134, United States
Related Publications (3)
Jan S, Steinway C, Belton T, Shults J, Bennett L, Teng O, Griffis H, Aygun B, Appiah-Kubi A, Apollonsky N, Boruchov D, Niss O, Schwartz L, Crosby L, Barakat L, Andemariam B, Mulchan SS, Rubin D, Smith-Whitley K. Community Health Worker and Mobile Health Interventions for Quality of Life Among Young Adults With Sickle Cell Disease: A Randomized Clinical Trial. JAMA Netw Open. 2025 Nov 3;8(11):e2543571. doi: 10.1001/jamanetworkopen.2025.43571.
PMID: 41247734DERIVEDBelton TD, Steinway CM, Teng O, Shults J, Barakat LP, Aygun B, Appiah-Kubi A, Crosby LE, Niss O, Andemariam B, Schwartz LA, Luma S, Smith KA, Johnson TB, Rubin DM, Smith-Whitley KM, Jan S. The Community Health Workers and Mobile Health for Emerging Adults Transitioning Sickle Cell Disease Care (COMETS) Trial: Protocol for a Randomized Controlled Trial. JMIR Res Protoc. 2025 Sep 4;14:e69239. doi: 10.2196/69239.
PMID: 40905609DERIVEDLalji R, Koh L, Francis A, Khalid R, Guha C, Johnson DW, Wong G. Patient navigator programmes for children and adolescents with chronic diseases. Cochrane Database Syst Rev. 2024 Oct 9;10(10):CD014688. doi: 10.1002/14651858.CD014688.pub2.
PMID: 39382077DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
David Rubin, MD
Children's Hospital of Philadelphia
- PRINCIPAL INVESTIGATOR
Sophia Jan, MD
Cohen's Children Medical Center/Northwell Health
- PRINCIPAL INVESTIGATOR
Kim Smith-Whitley, MD
Children's Hospital of Philadelphia
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- CARE PROVIDER, INVESTIGATOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 24, 2018
First Posted
August 27, 2018
Study Start
January 15, 2019
Primary Completion
August 31, 2024
Study Completion
August 31, 2024
Last Updated
December 4, 2024
Record last verified: 2024-12